Rothwell Investment Advisors, LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$175K	Buy	+755	New	+$187K	0.09%	189

Other funds holding JAZZ

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Rothwell Investment Advisors, LLC's JAZZ Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 755 shares worth $175K. The stake represents 0.09% of the portfolio and ranks #189 among its holdings.

331 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Rothwell Investment Advisors, LLC held 755 shares of Jazz Pharmaceuticals worth $175K as of Q3 2026.
Jazz Pharmaceuticals was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Jazz Pharmaceuticals made up 0.09% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #189 holding.
331 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.